Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 4.4 | 2.9 | 6.0 |
| Revenue growth | 52.3% | -52.0% | |
| Cost of goods sold | 7.0 | 5.3 | 7.4 |
| Gross profit | -2.6 | -2.5 | -1.4 |
| Gross margin | -59.8% | -85.6% | -23.9% |
| Research and development | 38.7 | 29.8 | 4.3 |
| General and administrative | 25.4 | 19.7 | 15.6 |
| EBIT | -46.9 | -49.3 | -21.3 |
| EBIT margin | -1071.6% | -1719.2% | -356.8% |
| Pre-tax income | -56.8 | -50.4 | -23.3 |
| Income taxes | 0.2 | 0.4 | 0.2 |
| Net income | -57.0 | -50.9 | -23.5 |
| Net margin | -1302.7% | -1772.0% | -392.9% |
| |
| Diluted EPS | ($2.12) | ($2.28) | ($2.41) |
| Shares outstanding (diluted) | 26.9 | 22.3 | 9.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|